LUCAR-E9D or LUCAR-E9K cells product
LB2406-0001
Phase 1 mab active
Quick answer
LUCAR-E9D or LUCAR-E9K cells product for B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory
- Phase
- Phase 1
- Modality
- mab
- Status
- active